Quesiton : A 72-year-old white male patient is on Coumadin therapy. Which of the following tests is commonly ordered to monitor the patient's Coumadin levels?A. bleeding timeB. blood smearC. partial thromboplastin timeD. prothrombin time
Answer: D
Most relevent text from all around web: A 72-year-old white male patient is on Coumadin therapy. Which of the following tests is commonly ordered to monitor the patient's Coumadin levels?A. bleeding timeB. blood smearC. partial thromboplastin timeD. prothrombin time
A 72-year -old white male patient is on Coumadin therapy . Which of the following tests is commonly ordered to monitor the patient's Coumadin levels? A . bleeding time B . blood smear C . partial thromboplastin time D . prothrombin time
Start studying Content Area V RHIT Exam: Medical Science. Learn vocabulary terms and more with flashcards games and other study tools. ... A 72 year old white male patient is on Coumadin therapy . Which of the following tests is commonly ordered to monitor the patient's Coumadin levels ?
Medical Science-multiple choice - Medical science-multiple choice ... A 72-year -old white male patient is on Coumadin therapy . Which of the following tests is commonly ordered to monitor the patient's Coumadin levels? A . bleeding time B . blood smear C . partial thromboplastin time D . prothrombin time
Chapter 24: Diagnostic Tests and Specimen Collection Test Bank MULTIPLE CHOICE 1. A patient who is on an anticoagulant ( Coumadin ) asks What did the physician mean when he said I was to have my blood tested every 2 weeks? The nurse explains It is important to monitor the effects of the drug to see how long it takes your blood to clot. The blood test the physician was talking about is the: a ...
Sat Feb 06 2010 · Male 84 yrs. old on Coumadin. Blood level just below 2 taken on 2-05. ... that bleeding has occured. Coumadin is notorious to have interactions with several foods like grapefruit and even many medications including antibiotics and OTC drugs such as zantac and prilosec.This could have ...

No comments:
Post a Comment